This article is more than 5 years old. Information may no longer be current.

Alimera reports $8.6 million net loss in second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alimera Sciences reported GAAP net loss applicable to common stockholders of $8.6 million, or $0.19 per share, in the second quarter compared with GAAP net income of $1.1 million, or $0.03 per share, in the second quarter of 2014, according to a press release.

The loss was attributed to non-cash items that included changes in the fair value of a derivative warrant liability, unrealized gains and losses in foreign currency, and reserves for potential inventory expiration, the release said.

Total net revenue was reported at $5.8 million in the second quarter, a 164% increase from $2.2 million in the second quarter of the previous year.

Sales and marketing expenses were reported at $6.9 million in the second quarter, a 130% increase from $3 million in the second quarter of the previous year.